+948.4%
MRNA vs NTAP
+186.4%
+762.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -7.4% | +5.2% | -0.6% |
| 7D | -12.7% | -13.1% | +0.4% | -10.0% |
| 30D | -20.7% | -27.4% | +6.8% | -15.2% |
| 3M | +46.3% | -18.1% | +64.3% | +51.9% |
| 6M | +305.2% | +33.2% | +272.0% | +253.2% |
| YTD | +561.2% | +49.5% | +511.8% | +451.6% |
| 1Y | +772.1% | +55.1% | +717.0% | +619.2% |
| 3Y | +147.0% | +113.5% | +33.4% | +83.6% |
| 5Y | -26.1% | +104.7% | -130.8% | -45.3% |
| All | +948.4% | +186.4% | +762.0% | +608.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling